![John Bondo Hansen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van John Bondo Hansen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Pcovery ApS
![]() Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | - | - |
Operationeel Directeur | 26-08-2011 | - | |
Conrig Pharma ApS
![]() Conrig Pharma ApS Pharmaceuticals: MajorHealth Technology Conrig Pharma ApS provides drug for oral treatment of atopical disease. Its new drug (CRG-010) is use for topical treatment of itch/pruritus associated with atopical dermatitis. The company was founded by John Bondo Hansen and Mikael Sondergaard Thomsen on December 20, 2010 and is headquartered in Copenhagen, Denmark. | Directeur/Bestuurslid | 20-12-2010 | - |
Algemeen Directeur | 20-12-2010 | - | |
Oprichter | 20-12-2010 | - |
Loopbaan van John Bondo Hansen
Eerdere bekende functies van John Bondo Hansen
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Sound Biotechnology, Inc. | Hoofd Techniek/Wetenschap/O&O | 01-01-2010 | 01-01-2010 |
Oprichter | 01-01-2008 | 01-01-2010 | |
NOVO NORDISK A/S | Corporate Officer/Principal | 01-01-2002 | - |
Contera Pharma ApS
![]() Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Contera Pharma ApS is a holding company that identifies and develops treatments for patients suffering from movement disorders. It develops drug candidates based on a combination of repositioning, combinations, and reformulations. The firm's lead project JM-010 is for treatment of dyskinesia associated with Parkinson's disease. It develops an approach of using a combination therapy to tackle clinically relevant synergistic pathways to obtain therapeutic effects which will generate efficacious therapeutic entities based on robust pre-clinical and clinical evidence. The company was founded by Mikael Søndergaard Thomsen and John Bondo Hansen in 2010 and is headquartered in Copenhagen, Denmark. | Algemeen Directeur | - | - |
Oprichter | - | - | |
Konticon Consulting, Inc. | Algemeen Directeur | 01-01-2008 | - |
Oprichter | 01-01-2008 | - | |
Aurigene Discovery Technologies Ltd.
![]() Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. | Directeur/Bestuurslid | 26-08-2011 | - |
Opleiding van John Bondo Hansen
University of Copenhagen | Doctorate Degree |
Statistieken
Internationaal
Denemarken | 6 |
Verenigde Staten | 3 |
India | 2 |
Operationeel
Founder | 4 |
Chief Executive Officer | 3 |
Corporate Officer/Principal | 2 |
Sectoraal
Health Technology | 6 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
NOVO NORDISK A/S | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Pcovery ApS
![]() Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | Health Technology |
Aurigene Discovery Technologies Ltd.
![]() Aurigene Discovery Technologies Ltd. BiotechnologyHealth Technology Aurigene Discovery Technologies Ltd. operates as biotechnology company. It offers research services such as integrated research and stand-alone research. The company is headquartered in Bangalore, India. | Health Technology |
Sound Biotechnology, Inc. | |
Konticon Consulting, Inc. | |
Conrig Pharma ApS
![]() Conrig Pharma ApS Pharmaceuticals: MajorHealth Technology Conrig Pharma ApS provides drug for oral treatment of atopical disease. Its new drug (CRG-010) is use for topical treatment of itch/pruritus associated with atopical dermatitis. The company was founded by John Bondo Hansen and Mikael Sondergaard Thomsen on December 20, 2010 and is headquartered in Copenhagen, Denmark. | Health Technology |
Contera Pharma ApS
![]() Contera Pharma ApS Pharmaceuticals: MajorHealth Technology Contera Pharma ApS is a holding company that identifies and develops treatments for patients suffering from movement disorders. It develops drug candidates based on a combination of repositioning, combinations, and reformulations. The firm's lead project JM-010 is for treatment of dyskinesia associated with Parkinson's disease. It develops an approach of using a combination therapy to tackle clinically relevant synergistic pathways to obtain therapeutic effects which will generate efficacious therapeutic entities based on robust pre-clinical and clinical evidence. The company was founded by Mikael Søndergaard Thomsen and John Bondo Hansen in 2010 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Beurs
- Insiders
- John Bondo Hansen
- Ervaring